Skip to main content

Table 8 Multivariate analysis of clinical features and ERβ1 expression (Allred) with disease specific survival

From: Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

Feature (reference)

HR [CI 95%]

p value

ERβ1 Allred 1–4 (vs. ERβ1 Allred 0)

1.03 [0.34–3.19]

0.953

ERβ1 Allred 5 + (vs. ERβ1 Allred 0)

1.04 [0.34–3.24]

0.939

Agea

1.04 [1.01–1.07]

0.0141*

Stage IIA

5.33 [1.17–24-26]

0.0304*

Stage IIB

6.64 [1.32–33.46]

0.0217*

Stage III/IV

5.76 [1.12–33.46]

0.0344*

Chemotherapy Yes (vs no)

0.70 [0.27–1.85]

0.474

  1. Footnote: aContinuous (years). * P<0.05